U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143188) titled 'The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares' on Aug. 19.
Brief Summary: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract that affect millions of people in the United States of America. Among patients with IBD, symptomatic flares are quite common; up to 40-50% of patients in some populations report having a flare at least once per month. For most patients with IBD flares, the typical outpatient treatment consists of corticosteroids and, in some instances, initiation of or switching between 5-aminosalicyli...